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Purpose: In this case report, we present two cases of syringomyelia with optic neuropathy.
Findings: In Case 1, a 36-year-old Malay lady presented to our clinic with acute onset of blur-
ring of vision in her left eye that she experienced since past 1 month. She was diagnosed with 
syringomyelia 12 years ago and was on conservative management. Her visual acuity was 6/6 in 
the right eye and counting fingers at 1 m in the left. There was a positive relative afferent pupillary 
defect in her left eye. Optic nerve functions of her left eye were reduced. Visual field showed 
a left inferior field defect. Her extraocular muscle movements were full. Magnetic resonance 
imaging of the brain and spine showed syringomyelia at the level of C2–C6 and T2–T9. Both of 
her optic nerves were normal. Her condition improved with intravenous and oral corticosteroids. 
In Case 2, a 44-year-old Malay lady presented to our clinic with a progressive central scotoma 
in her right eye that she experienced since past 1 month. She had previous history of recurrent 
episodes of weakness in both of her lower limbs from past 8 months. Visual acuity in her right 
and left eye was 6/9 and 6/6, respectively. The relative afferent pupillary defect in her right eye 
was positive. Optic nerve functions of her right eye were affected. Visual field showed a central 
scotoma in her right eye. Her extraocular muscle movements were full. Fundoscopy of her right 
eye showed a pale optic disc. Her left eye fundus was normal. Magnetic resonance imaging of 
the brain and spine showed syringomyelia at T3–T6. Both of her optic nerves were normal. A 
diagnosis of syringomyelia with right optic atrophy was performed. Her condition improved 
with intravenous and oral corticosteroids.
Conclusion: Optic neuropathy is a rare neuro-ophthalmic manifestation in patients with 
syringomyelia. Prompt diagnosis and timely management are essential to avoid a poor visual 
outcome. Intravenous corticosteroids are beneficial in the treatment of early optic neuropathy 
in syringomyelia.
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Introduction
Syringomyelia is a chronic and progressive disease affecting the spine or cranioverte-
bral junction in which long cavities form within the spinal cord.1 Neurological mani-
festations of syringomyelia include pain, motor symptoms, sensory disturbances and 
brainstem signs. Common ocular features are downbeat nystagmus and oscillopsia.2 
Papilloedema and optic atrophy have been described as rare signs. Herein, we present 
two rare cases of optic neuropathy in patients with syringomyelia, which is an uncom-
mon manifestation of the disease.
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Findings
Case 1
A 36-year-old Malay lady presented to our clinic with acute 
onset of blurring of vision in her left eye that she experienced 
since past 1 month. She had been diagnosed with syringomy-
elia 12 years ago when she had first experienced acute bilat-
eral lower limb weakness 1 month postdelivery. Her magnetic 
resonance imaging of the spine had revealed syringomyelia. 
Since then, she was monitored by a neurosurgical team and 
was being managed conservatively.
On examination in our clinic, visual acuity of her right eye 
was found to be 6/6 and counting fingers at 1 m in the left. 
There was a positive relative afferent pupillary defect in her 
left eye. The optic nerve functions such as light brightness, 
red saturation and color vision of her left eye were affected. 
Visual field showed a left inferior field defect. Her extraocular 
muscle movements were full. Both anterior and posterior seg-
ments appeared normal. Neurological examination showed 
bilateral lower limb weakness with intact sensation. Other 
examinations related to cranial nerves were normal. Magnetic 
resonance imaging of the brain and spine showed syringo-
myelia at the level of C2–C6 and T2–T9 (Figures 1 and 2). 
However, both of her optic nerves were normal (Figure 3).
A diagnosis of left retrobulbar optic neuritis was per-
formed. She was started on intravenous methylprednisolone 
at a dosage of 250 mg four times a day for a period of 5 days, 
 followed by oral prednisolone at a dosage of 45 mg (1 mg/
kg/day) once daily for 9 days. Her condition dramatically 
improved after treatment. Visual acuity of her left eye was 6/24, 
and her optic nerve functions improved. She was continued 
with oral prednisolone with tapering dose weekly for another 
1 month. Her visual acuity improved to 6/6 with good optic 
nerve functions. Oral prednisolone was off after 2 months. 
There was no complication due to the use of corticosteroids. 
Her vision remained good during 6 months follow-up.
Case 2
A 44-year-old Malay lady presented to our clinic with a pro-
gressive central scotoma in her right eye that she experienced 
since past 1 month. She had previous history of recurrent 
episodes of weakness in both of her lower limbs from past 
8 months. She was admitted to a center for investigations; 
however, a proper diagnosis could not be established. She was 
treated conservatively. This was the first ocular presentation.
On examination, visual acuity in her right and left eye was 
6/9 and 6/6, respectively. The relative afferent pupillary defect 
in the right eye was positive. The optic nerve functions such 
as light brightness, red saturation and color vision of the right 
eye were affected. Visual field showed a central scotoma in 
the right eye. Her extraocular muscle movements were full. 
Both anterior segments were unremarkable. Fundoscopy of 
her right eye showed a pale optic disc. Her left eye fundus was 
Figure 1 Linear signal hypointensity from C2 to C6 and T2 to T9 vertebra level on 
T1 weighted imaging (arrow).
Figure 2 Linear signal hyperintensity from C2 to C6 and T2 to T9 vertebra level on 
T2 weighted imaging (arrow).
 
In
te
rn
at
io
na
l M
ed
ica
l C
as
e 
Re
po
rts
 J
ou
rn
al
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
20
2.
17
0.
57
.2
41
 o
n 
14
-S
ep
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Medical Case Reports Journal 2017:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
89
syringomyelia with unilateral optic neuropathy
normal. Neurological examination showed bilateral lower limb 
weakness with intact sensation. Other examinations related to 
cranial nerves were normal. Magnetic resonance imaging of 
the brain and spine showed syringomyelia at the level of T3–T6 
(Figures 4 and 5). However, both optic nerves were normal.
She was diagnosed with syringomyelia with right optic 
atrophy. She was started on intravenous methylprednisolone 
at a dosage of 250 mg four times a day for 5 days, followed 
by oral prednisolone at a dosage of 40 mg (1 mg/kg/day) 
once daily for 9 days. Her condition improved after 2 weeks 
of treatment, with reduction in the right eye central scotoma. 
However, due to the preexisting optic atrophy, visual acuity in 
her right eye was 6/9. Her optic nerve functions persistently 
reduced compared to her left eye. She was continued with oral 
prednisolone with tapering dose weekly. Subsequent follow-
up at 1 month after diagnosis showed that her ocular condition 
was stable. Her limb weakness improved slightly, but she 
remained wheelchair bound. There was no complication of 
treatment. Her condition was stable at 6 months follow-up.
Discussion
Syringomyelia is a chronic disease, in which fluid-filled 
cavities in the spinal cord called syrinx expand and elongate 
over time. In this process, they destroy the nerve fibers of the 
spinal cord that lead to a variety of neurological manifesta-
tions, depending on the size and location of the syrinx.3 Optic 
neuritis is an extremely rare neuro-ophthalmic manifestation 
in syringomyelia. Previous published reports have only noted 
the occurrence of optic neuritis when syringomyelia occurs 
in patients with multiple sclerosis.4,5 Herein, we report two 
cases of optic neuritis in patients with syringomyelia; one 
patient had an acute episode of optic neuritis, whereas the 
other had already developed optic atrophy, which may have 
been preceded by a subacute attack of optic neuritis, in view 
Figure 3 Fundus photo showing both optic discs to be normal.
Figure 4 Linear signal hypointensity from T3 to T6 vertebra level on T1 weighted 
imaging (arrow).
Figure 5 Linear signal hyperintensity from T3 to T6 vertebra level on T2 weighted 
imaging (arrow).
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of the diminished optic nerve function tests and central 
scotoma in that eye.
Although these two cases of syringomyelia were idiopathic, 
Chiari type-1 malformation has been reported as one of the 
etiologic factors in syringomyelia.6 It has been postulated that 
idiopathic syringomyelia is similar to that seen in Chiari type-1 
malformation in terms of its pathogenesis.7 This malformation, 
also known as hindbrain hernia, is a structural abnormality in 
the region of craniovertebral junction, causing cerebellar tonsils 
to go below the foramen magnum and obstruct cerebrospinal 
fluid circulation.6 The rise in spinal subarachnoid pressure 
subsequently causes fluid to move upward inside the syrinx 
and into the brainstem, leading to a condition known as syrin-
gobulbia.8 There may be paralysis of the cranial nerves, which 
explains the diplopia experienced by some patients. Patients can 
present with diplopia, oscillopsia, nystagmus, anisocoria and 
ptosis in cases of hindbrain-related syringomyelia.2,9 Another 
syringomyelia-associated neuro-ophthalmic condition is Horner 
syndrome, which shows compression along the course of the 
sympathetic pathway by a lower cervical syrinx.10
The optic disc pallor occurring in many patients with 
syringomyelia is most likely due to the chronicity of the 
intracranial hypertension. Intracranial hypertension leads 
to papilloedema, which when long-standing, results in optic 
atrophy and generally irreversible reduction in optic nerve 
functions. Optic atrophy in patients with syringomyelia can 
be due to increased intracranial pressure caused by closure 
of the foramina at the roof of the fourth ventricle.11 Due to 
the underlying anatomical basis of the diagnosis of this con-
dition, it is almost impossible to diagnose it when patients 
present with visual complaints in the absence of neurological 
symptoms. The introduction of magnetic resonance imaging 
has improved the pickup rate of this condition; nevertheless, a 
high index of suspicion is required for the clinician to perform 
this imaging not just for the brain, as is common practice in 
optic neuritis, but also for the spine.
The management of syringomyelia depends on the initial 
presentation and its progression. Since the natural history of 
syringomyelia in any individual patient is not immediately 
apparent, a conservative approach can be recommended, with 
close follow-up and periodic examination using magnetic res-
onance imaging. When there is progression in the neurologi-
cal deficit, definitive treatment is required.  Craniovertebral 
decompression may result in improvement in neurological 
symptoms and signs.12,13 This is probably due to release of 
pressure and traction on cranial nerves. However, till date, due 
to the rarity and variability of associated  neuro-ophthalmic 
manifestations, there is no clear evidence of the management 
of these conditions in syringomyelia.
In both of our patients, even the one with optic atrophy, 
commencement of systemic corticosteroids was associ-
ated with improvement in visual function. The patients’ 
improved vision function may be related to the effect of 
corticosteroids on reducing the size of the syrinx, as has 
been demonstrated by Matsuda et al.14 The Optic Neuritis 
Treatment Trials found that although high-dose intravenous 
corticosteroids followed by oral maintenance produce a 
more rapid recovery of vision among patients with acute 
optic neuritis, corticosteroids did not improve the final 
visual acuity or optic nerve functions.15 Extrapolating the 
findings of this trial to our study, this corticosteroid regime 
may also have utility in the management of optic neuropathy 
in syringomyelia. In our patient with a delayed presentation 
to hospital, optic atrophy had already developed, suggesting 
that unlike the typical optic neuritis, which tends to resolve 
spontaneously and thus may be managed conservatively, 
optic neuritis in patients with syringomyelia should be 
aggressively treated.
Conclusion
Optic neuropathy is a rare neuro-ophthalmic manifestation 
in patients with syringomyelia. Prompt diagnosis and timely 
management are essential to avoid a poor visual outcome. 
Intravenous corticosteroids are beneficial in the treatment of 
early optic neuropathy in syringomyelia.
Disclosure
The authors declare that they have no conflicts of interest 
in this work.
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